Varex Imaging (NASDAQ:VREX) Director Jay Kunkel Sells 4,510 Shares

Varex Imaging (NASDAQ:VREX) Director Jay Kunkel sold 4,510 shares of the business’s stock in a transaction on Friday, March 20th. The shares were sold at an average price of $11.14, for a total transaction of $50,241.40. Following the sale, the director directly owned 23,450 shares in the company, valued at approximately $261,233. This trade represents a 16.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Varex Imaging Stock Performance

Shares of Varex Imaging stock opened at $10.82 on Tuesday. The stock has a market cap of $453.36 million, a PE ratio of -6.60 and a beta of 0.88. The business has a fifty day simple moving average of $13.06 and a 200-day simple moving average of $12.25. The company has a quick ratio of 1.87, a current ratio of 3.89 and a debt-to-equity ratio of 0.75. Varex Imaging has a 12 month low of $6.76 and a 12 month high of $14.56.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.05. The firm had revenue of $209.60 million for the quarter, compared to analyst estimates of $207.83 million. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. On average, sell-side analysts anticipate that Varex Imaging will post 0.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on VREX. B. Riley Financial restated a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th. Jefferies Financial Group reiterated a “hold” rating and issued a $14.50 price objective on shares of Varex Imaging in a research note on Monday, February 2nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a research report on Monday, December 29th. Finally, Wall Street Zen raised shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 28th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Varex Imaging presently has an average rating of “Hold” and an average target price of $16.17.

Institutional Investors Weigh In On Varex Imaging

Several institutional investors have recently made changes to their positions in the company. LSV Asset Management raised its holdings in shares of Varex Imaging by 210.7% during the 4th quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock valued at $14,496,000 after purchasing an additional 843,805 shares in the last quarter. Millennium Management LLC lifted its stake in shares of Varex Imaging by 119.8% in the 3rd quarter. Millennium Management LLC now owns 913,169 shares of the company’s stock valued at $11,323,000 after purchasing an additional 497,650 shares during the last quarter. Qube Research & Technologies Ltd boosted its holdings in Varex Imaging by 2,514.9% in the second quarter. Qube Research & Technologies Ltd now owns 318,127 shares of the company’s stock worth $2,758,000 after purchasing an additional 305,961 shares in the last quarter. Deerfield Management Company L.P. bought a new stake in Varex Imaging in the third quarter worth $3,537,000. Finally, Neuberger Berman Group LLC increased its position in Varex Imaging by 22.8% during the second quarter. Neuberger Berman Group LLC now owns 1,497,175 shares of the company’s stock worth $12,974,000 after buying an additional 277,870 shares during the last quarter.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.